
Am Fam Physician. 2022;105(1):20-21
Author disclosure: No relevant financial relationships.
Peanut allergen powder (Palforzia) is an allergen extract for oral immunotherapy. It is labeled for the mitigation of allergic and anaphylactic reactions to accidental exposure to small amounts of peanuts in patients with a confirmed diagnosis of peanut allergy. Use of peanut allergen powder may be initiated in children four to 17 years of age and maintained in adults 18 years and older.1

Drug | Dosage | Dose form | Cost of full course* |
---|---|---|---|
Peanut allergen powder (Palforzia) | Three phases of dosing: initial escalation, up-dosing, and maintenance | 0.5-mg to 100-mg capsules; 300-mg sachets | $3,000 |
Subscribe
From $165- Immediate, unlimited access to all AFP content
- More than 130 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available